Wave Life Sciences Ltd. Ordinary Shares (WVE) is a publicly traded Healthcare sector company. As of November 11, 2026, WVE trades at $3.47 with a market cap of $686.36M and a P/E ratio of -3.24. WVE moved +1.61% today. Year to date, WVE is -78.65%; over the trailing twelve months it is -51.70%. Its 52-week range spans $3.04 to $21.73. Analyst consensus is strong buy with an average price target of $17.03. Rallies surfaces WVE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
14 analysts cover WVE: 0 strong buy, 13 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $17.03.
| Metric | Value |
|---|---|
| Price | $3.47 |
| Market Cap | $686.36M |
| P/E Ratio | -3.24 |
| EPS | $-1.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.73 |
| 52-Week Low | $3.04 |
| Volume | 2.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $65.37M |
| Net Income | $-202.47M |
| Gross Margin | 0.00% |
14 analysts cover WVE: 0 strong buy, 13 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.03.